Intellia Therapeutics
James Butler is an experienced leader in the biotechnology field, currently serving as General Manager at Intellia Therapeutics, Inc. since January 2020. Butler's progressive roles at Intellia include Vice President of Program Leadership, Senior Director of Program Team Lead, and Director of Program Management. Prior to this, Butler contributed to Alnylam Pharmaceuticals from December 2008 to January 2020 as Associate Director. Earlier experience includes a Postdoctoral Associate position at Baker Lab, MIT from October 2006 to November 2008. James Butler holds a Ph.D. in Biochemistry and Molecular Biology from Upstate Medical University (1999-2005) and a Bachelor of Science in Biochemistry from St. Bonaventure University (1995-1999).
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.